• Profile
Close

Mir-17 and miR-93 promote tumor progression by targeting p21 in patients with chordoma

OncoTargets and Therapy May 17, 2021

Dong W, Li J, Dong X, et al. - Researchers investigated the role of two micorRNAs (miRNAs), miR-17 and miR-93, as well as their potential mechanisms in chordoma. They used quantitative real-time polymerase chain reaction, Kaplan–Meier survival curve, and Cox regression analysis to determine the expression as well as prognostic value of miR-17 and miR-93. They found chordoma tissues exhibited high expression of miR-17/93, which was linked with poor prognosis. A contributor to cell proliferation, colony formation, and invasion, was overexpression of miR-17/93. Findings showed that miR-17/93 exerts a potential oncogenic impact on chordoma progression, and miR-17/93-p21 axis was indicated as a promising treatment target in chordoma.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay